Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The new screenshot shows only minor visual/layout adjustments with no changes to core study details such as eligibility criteria, interventions, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:00:05.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    - The page now includes a notice about potential government funding lapse and current operating status, plus a link to the NIH Clinical Center and opm.gov for updates. - The version is updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T09:22:04.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:07:36.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.3%
    Check dated 2025-09-13T16:39:13.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T14:10:47.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several key medical topics and terms related to pembrolizumab and lung cancer have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:07:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.